Annual SGA
$50.35 M
+$23.77 M+89.45%
December 31, 2023
Summary
- As of February 8, 2025, VRNA annual SGA is $50.35 million, with the most recent change of +$23.77 million (+89.45%) on December 31, 2023.
- During the last 3 years, VRNA annual SGA has risen by +$20.58 million (+69.13%).
- VRNA annual SGA is now at all-time high.
Performance
VRNA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$35.20 M
-$13.84 M-28.22%
September 30, 2024
Summary
- As of February 8, 2025, VRNA quarterly SGA is $35.20 million, with the most recent change of -$13.84 million (-28.22%) on September 30, 2024.
- Over the past year, VRNA quarterly SGA has dropped by -$13.84 million (-28.22%).
- VRNA quarterly SGA is now -28.22% below its all-time high of $49.03 million, reached on June 30, 2024.
Performance
VRNA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.82 B
-$154.43 M-9.29%
September 30, 2024
Summary
- As of February 8, 2025, VRNA TTM SGA is -$1.82 billion, with the most recent change of -$154.43 million (-9.29%) on September 30, 2024.
- Over the past year, VRNA TTM SGA has dropped by -$1.91 billion (-1957.60%).
- VRNA TTM SGA is now -16977857.01% below its all-time high of $10.70 thousand.
Performance
VRNA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
VRNA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +89.5% | -28.2% | -1957.6% |
| 3 y3 years | +69.1% | +223.4% | -4687.0% |
| 5 y5 years | +530.6% | +1352.0% | -10000.0% |
VRNA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +89.5% | -28.2% | +565.3% | -84.7% | at low |
| 5 y | 5-year | at high | +404.2% | -28.2% | +1344.2% | -295.0% | at low |
| alltime | all time | at high | +3486.7% | -28.2% | +7423.7% | <-9999.0% | at low |
Verona Pharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $35.20 M(-28.2%) | $119.64 M(+22.3%) |
| Jun 2024 | - | $49.03 M(+140.0%) | $97.79 M(+59.8%) |
| Mar 2024 | - | $20.43 M(+36.5%) | $61.20 M(+21.5%) |
| Dec 2023 | $50.35 M(+89.4%) | $14.97 M(+12.1%) | $50.35 M(+15.2%) |
| Sep 2023 | - | $13.35 M(+7.3%) | $43.70 M(+22.6%) |
| Jun 2023 | - | $12.44 M(+29.7%) | $35.64 M(+24.1%) |
| Mar 2023 | - | $9.59 M(+15.2%) | $28.73 M(+8.1%) |
| Dec 2022 | $26.58 M(-21.6%) | $8.32 M(+57.3%) | $26.58 M(+10.7%) |
| Sep 2022 | - | $5.29 M(-4.3%) | $24.01 M(-18.9%) |
| Jun 2022 | - | $5.53 M(-25.7%) | $29.61 M(-7.7%) |
| Mar 2022 | - | $7.44 M(+29.2%) | $32.06 M(-5.4%) |
| Dec 2021 | $33.91 M(+13.9%) | $5.76 M(-47.1%) | $33.91 M(-14.4%) |
| Sep 2021 | - | $10.88 M(+36.3%) | $39.60 M(+7.0%) |
| Jun 2021 | - | $7.99 M(-14.0%) | $37.01 M(+15.0%) |
| Mar 2021 | - | $9.28 M(-19.0%) | $32.19 M(+8.1%) |
| Dec 2020 | $29.77 M(+198.1%) | $11.45 M(+38.3%) | $29.77 M(+43.4%) |
| Sep 2020 | - | $8.28 M(+161.2%) | $20.75 M(+39.3%) |
| Jun 2020 | - | $3.17 M(-53.8%) | $14.89 M(+3.3%) |
| Mar 2020 | - | $6.86 M(+181.6%) | $14.42 M(+45.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $9.99 M(+25.1%) | $2.44 M(+0.5%) | $9.95 M(+5.4%) |
| Sep 2019 | - | $2.42 M(-10.2%) | $9.44 M(+6.5%) |
| Jun 2019 | - | $2.70 M(+13.0%) | $8.86 M(+4.5%) |
| Mar 2019 | - | $2.39 M(+23.7%) | $8.48 M(+4.2%) |
| Dec 2018 | $7.99 M(-1.4%) | $1.93 M(+4.6%) | $8.14 M(+7.8%) |
| Sep 2018 | - | $1.85 M(-20.3%) | $7.55 M(-10.5%) |
| Jun 2018 | - | $2.32 M(+13.4%) | $8.44 M(-2.8%) |
| Mar 2018 | - | $2.04 M(+52.2%) | $8.68 M(+9.5%) |
| Dec 2017 | $8.10 M(+179.8%) | $1.34 M(-50.9%) | $7.93 M(+4.1%) |
| Sep 2017 | - | $2.73 M(+6.7%) | $7.62 M(+29.9%) |
| Jun 2017 | - | $2.56 M(+99.0%) | $5.86 M(+55.6%) |
| Mar 2017 | - | $1.29 M(+24.5%) | $3.77 M(+51.9%) |
| Dec 2016 | $2.89 M(+16.6%) | $1.03 M(+5.5%) | $2.48 M(+71.4%) |
| Sep 2016 | - | $979.70 K(+109.4%) | $1.45 M(+209.4%) |
| Jun 2016 | - | $467.80 K | $467.80 K |
| Dec 2015 | $2.48 M(+39.0%) | - | - |
| Dec 2014 | $1.79 M(-6.7%) | - | - |
| Dec 2013 | $1.91 M(+30.1%) | - | - |
| Dec 2012 | $1.47 M(+4.8%) | - | - |
| Dec 2011 | $1.40 M | - | - |
FAQ
- What is Verona Pharma annual SGA?
- What is the all time high annual SGA for Verona Pharma?
- What is Verona Pharma annual SGA year-on-year change?
- What is Verona Pharma quarterly SGA?
- What is the all time high quarterly SGA for Verona Pharma?
- What is Verona Pharma quarterly SGA year-on-year change?
- What is Verona Pharma TTM SGA?
- What is the all time high TTM SGA for Verona Pharma?
- What is Verona Pharma TTM SGA year-on-year change?
What is Verona Pharma annual SGA?
The current annual SGA of VRNA is $50.35 M
What is the all time high annual SGA for Verona Pharma?
Verona Pharma all-time high annual SGA is $50.35 M
What is Verona Pharma annual SGA year-on-year change?
Over the past year, VRNA annual SGA has changed by +$23.77 M (+89.45%)
What is Verona Pharma quarterly SGA?
The current quarterly SGA of VRNA is $35.20 M
What is the all time high quarterly SGA for Verona Pharma?
Verona Pharma all-time high quarterly SGA is $49.03 M
What is Verona Pharma quarterly SGA year-on-year change?
Over the past year, VRNA quarterly SGA has changed by -$13.84 M (-28.22%)
What is Verona Pharma TTM SGA?
The current TTM SGA of VRNA is -$1.82 B
What is the all time high TTM SGA for Verona Pharma?
Verona Pharma all-time high TTM SGA is $10.70 K
What is Verona Pharma TTM SGA year-on-year change?
Over the past year, VRNA TTM SGA has changed by -$1.91 B (-1957.60%)